| 000 | 01725 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517224020.0 | ||
| 264 | 0 | _c20201019 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a1532-6551 | ||
| 024 | 7 |
_a10.1007/s12350-018-1325-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHop, H | |
| 245 | 0 | 0 |
_aNone _h[electronic resource] |
| 260 |
_bJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology _c08 2019 |
||
| 300 |
_a1064-1075 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCalcinosis _xdiagnostic imaging |
| 650 | 0 | 4 |
_aCarotid Arteries _xdiagnostic imaging |
| 650 | 0 | 4 |
_aCarotid Stenosis _xdiagnostic imaging |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorine Radioisotopes |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSodium Fluoride |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 | _aX-Ray Microtomography |
| 700 | 1 | _ade Boer, S A | |
| 700 | 1 | _aReijrink, M | |
| 700 | 1 | _aKamphuisen, P W | |
| 700 | 1 | _ade Borst, M H | |
| 700 | 1 | _aPol, R A | |
| 700 | 1 | _aZeebregts, C J | |
| 700 | 1 | _aHillebrands, J L | |
| 700 | 1 | _aSlart, R H J A | |
| 700 | 1 | _aBoersma, H H | |
| 700 | 1 | _aDoorduin, J | |
| 700 | 1 | _aMulder, D J | |
| 773 | 0 |
_tJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology _gvol. 26 _gno. 4 _gp. 1064-1075 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12350-018-1325-5 _zAvailable from publisher's website |
| 999 |
_c28569904 _d28569904 |
||